Alkermes (ALKS) Operating Expenses (2010 - 2026)
Alkermes (ALKS) posted quarterly Operating Expenses of $477.7 million for Q2 2026, up 60.46% year-over-year from $297.7 million in Q2 2025, and up 8.27% quarter-over-quarter from $441.2 million in Q1 2026.
Alkermes (ALKS) Operating Expenses (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Operating Expenses for 17 consecutive years, with $477.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Expenses rose 60.46% year-over-year to $477.7 million; the TTM figure through Jun 2026 stood at $1.6 billion (up 37.07% YoY), while the FY2025 annual figure was $1.2 billion, up 7.47% from the prior year.
- Operating Expenses rose to $477.7 million in Q2 2026 per ALKS's latest filing, from $441.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $477.7 million in Q2 2026 and bottomed at $189.1 million in Q4 2022.
- Historically, Operating Expenses has averaged $313.6 million across 5 years, with a median of $305.1 million in 2022.
- Annual changes were most pronounced in 2023 — Operating Expenses soared 70.74% — and 2024, when it declined 17.21%.
- Alkermes' Operating Expenses stood at $189.1 million in 2022, then jumped by 70.74% to $322.8 million in 2023, then slipped by 17.21% to $267.3 million in 2024, then climbed by 22.13% to $326.4 million in 2025, then jumped by 46.32% to $477.7 million in 2026.
- Business Quant data shows ALKS's Operating Expenses at $477.7 million in Q2 2026, $441.2 million in Q1 2026, and $326.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 477.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 477.66 Mn |
| Mar 31, 2026 | 441.19 Mn |
| Dec 31, 2025 | 326.44 Mn |
| Sep 30, 2025 | 305.10 Mn |
| Jun 30, 2025 | 297.68 Mn |
| Mar 31, 2025 | 292.72 Mn |
| Dec 31, 2024 | 267.30 Mn |
| Sep 30, 2024 | 273.39 Mn |
| Jun 30, 2024 | 289.25 Mn |
| Mar 31, 2024 | 307.06 Mn |
| Dec 31, 2023 | 322.84 Mn |
| Sep 30, 2023 | 291.74 Mn |
| Jun 30, 2023 | 336.13 Mn |
| Mar 31, 2023 | 298.57 Mn |
| Dec 31, 2022 | 189.08 Mn |
| Sep 30, 2022 | 313.00 Mn |
| Jun 30, 2022 | 310.68 Mn |
| Mar 31, 2022 | 305.13 Mn |
| Dec 31, 2021 | 195.05 Mn |
| Sep 30, 2021 | 313.80 Mn |